AI
VC

Accelmed Ventures II

United Statesaccelmed.com

Accelmed Ventures II is a venture capital firm based in the United States, investing in Healthcare & Life Sciences, Software & Developer Tools and Artificial Intelligence & Data, 14 tracked investments.

14
Investments Tracked

About Accelmed Ventures II

Operating out of the United States, Accelmed Ventures II is a venture capital firm. Our dataset covers 14 investments involving Accelmed Ventures II.

Recorded deals span Healthcare & Life Sciences, Software & Developer Tools, Artificial Intelligence & Data and Medical Devices. Coverage extends to 8 sectors in total. Participation spans Series B and Series C+ rounds.

Accelmed Ventures II invests in innovative medical device companies. They focus on late-stage companies with disruptive technologies.

Investment Focus

Stage Focus
series-bseries-c-plus
Sectors
Healthcare & Life SciencesSoftware & Developer ToolsArtificial Intelligence & Datamedical devicesgastroenterologyemailwearablesinternet

Investment Thesis

Accelmed Ventures II invests in innovative medical device companies. They focus on late-stage companies with disruptive technologies.

Accelmed Ventures II Portfolio Companies

16 tracked holdings.

Portfolio outcomes
35 active7 acquired13.0% exit rate

Team

Dr. Uri GeigerManaging Partner

Uri Geiger brings extensive entrepreneurial, management and investment know-how, having created and built many successful medical device enterprises.

Stephen RubinGeneral Partner

Steve joins Accelmed from Proskauer, where he was previously co-head of the Private Equity Group.

Daniel CohenVenture Partner

Daniel brings extensive investment experience with successful Medtech & Biotech investments over the last 20 years.

Dr. Irit YanivVenture Partner

Dr. Irit Yaniv is an experienced HealthTech investor and executive. Joining Accelmed in 2014, she plays an important role in leading Accelmed Ventures' portfolio companies.

Dr. Guy OhadChief Medical Officer

Dr. Guy Ohad is a radiologist with extensive experience in across both the technology and medical devices sectors.

Dr. Susan AlpertChief Regulatory Officer

Dr. Alpert began working with Accelmed in 2011. Previously, she had served as Corporate Senior Vice President for Global Regulatory Affairs at Medtronic.

Ilan Ben-OrenChief Technology Officer

Ilan Ben Oren brings more than 20 years’ experience in R&D and management in the medical technology sector.

Maria ForeroSenior Advisor

Maria brings over 25-years of experience in the healthcare sector, working alongside companies of all sizes and assisting them across an entire spectrum of

Explore Accelmed Ventures II's full profile on Brouky

Portfolio companies, co-investors, AI match scores, and deal flow signals.

Other Investors in United States

Other Investors in Healthcare & Life Sciences / Software & Developer Tools